ref.jpg

·Anthony S. Fauci, M.D, 2010, Nation instute of ALlerfyt and Infectious Disease, http://www.niaid.nih.gov/, Immune System
·
Marieb, E.N., Hoehn, K. (2007) Human Anatomy and Physiology, 7th edn, Benjamin Cummings New York.

·Blanco, P., Oaluckad, A., Pascuald, V. & Banchereaud, J. 2009, "Dendritic Cells and cytokines in human inflammatory and autoimmune dieseases", PMC, vol. 19, no. 1, pp. 41-52.

  • ·Bogaert, D. Weinberger, D. Thompson, C. Lipsitch, M. & Malley, R, 2009., Imparied Innate and Adaptive Immunity toStreptococcus pneumonia and its Effects on Colonization in an Infant Mouse Model, American Society for Microbiology, 77: 1613-1622.

· ·Jaspan, H. Lawn, S. Safrit, J. & Bekker, L, 2006, The maturing immune system: implications of development and testing HIV-1 vaccines for children and adolescents, AIDS, 20: 483-494.

· ·Liu, G. Zhang, L. & Zhao, Y, 2010, Modulation of immune responses through direct activation of Toll-like receptors to T cells,The Journal of Translational Immunology, 160: 168-175.

· ·Netea, M. Van Der Graaf, C. Van Der Meer, J & Kullberg, B, 2004, Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system, Journal of Leukoeyte Biology, 75: 749-755.

· ·Gallorini, S. Berti, F. Mancuso, G. Cozzi, R. Tortoli, M. Volpini, G. Telford, J. Beninati, C. Maione, D. & Wack, A, 2009, Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides,PNAS, 106: 17481-17486.

· ·Jane, V. & Levy, O, 2009, Developmental Biology of the Innate Immune Response: Implication for Neonatal and Infant Vaccine Development, The International Pediatric Research Foundation, 65: 98-105.

· ·Plotkin, S & Mortimer, E. 1988, Vaccines, 2nd edn, Philadelphia, United States.

· ·Anderson, K.V., Bokla, L. & Nüsslein-Volhard, C. 1985, "Establishment of dorsal - ventral polarity in the drosophila embryo: The induction of polarity by the Toll Gene product", Cell, vol. 42, no. 3, pp. 791-798.

· ·Flanagan, K.L., Burl, S. & Plebanski, M. 2010, "The Challenge of Assessing Infant Vaccine Responses in Resource poor Settings", Medscape Today, [Online], vol. 9, no. 6, pp. 2/9/2010. Available from: http://www.medscape.com/viewarticle/723928. [2/9/2010].

· ·Levy, O., Suter, E.E., Miller, R.L. & Wessels, M.R. 2008, "Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells", Blood, vol. 108, no. 4, pp. 1284-1290.

· ·Medzhitov, R., Hurlburt, P. & Janeway, C. 1997, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, vol. 388, no. 1, pp. 394-397.
· ·Nerren, J.R., He, H., Genovese, K.J. & Kogut, M.H. 2009, "mRNA Expression of the Avian Specific Toll-Like Receptor 15 is induced by Multiple Species of Bacteria", The Journal of Immunology, vol. 182, no. 135, pp. 135-135.
  • Norman, B. 2010, First evidence that the brain's native dendritic cells can muster an immune response, The Rockefeller University

· ·Rottinghaus, E., Vesosky, B. & Turner, J. 2010, "Elderly might not benefit from TB vaccines in development", Mechanisms of Ageing and Development, vol. 131, no. 6, pp. 605-614.

· ·Schnare, M., Barton, G.M., Holt, A.C., Takeda, S. & Medzhitov, R. 2001, "Toll-like receptors control activation of adaptive immune responses", Nature, vol. 2, no. 10, pp. 947-950.

  • Siegrist, C. 2008, "Section 1, General aspects of vaccination: Vaccine immunology" in Vaccines, 5th edn, Saunders, , pp. 17-35

· ·Shaw, A. 2008, "Vaccines Incorporating Toll-like Receptor Ligands", 2008, [Online], vol. 1, no. 1, pp. 1/9/2010. Available from: http://biopharminternational.findpharma.com/biopharm/article/articleDetail.jsp?id=557310&sk=&date=&&pageID=1. [1/9/2010].
  • Steinman, M.,R. & Pope, M. 2002, "Exploiting dendritic cells to improve vaccine efficieny", The Journal of Clinical Investigation, vol. 109, no. 12, pp. 1519-26


  • Turley, S. 2002, "Denditic cells: inciting and inhibiting autoimmunity", Current Opinion in Immunilogy, vol. 14, pp. 765-770.


  • Upham, J., Rate, A., Rowe, J., Kusel, M., Sly, P. & Holt, P. 2006, "Dendritic Cell Immaturity during Infancy Restricts the Capacity To Express Vaccine-Specific T-Cell Memory", Infection and immunity, [Online], vol. 74, no. 2, pp. 1106-. [2005]


  • Vogel, F. 2000, "Improving Vaccine Performance with Adjuvants", Clinical Infectious Diseases, , no. 30, pp. 266-270


· ·Antibody 2010, in MedlinePlus encyclopaedia, viewed 28 September 2010, MedlinePlus Online,http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm

· ·Beaver, C, 2010, ‘Strategic immunogenicity testing’, [[file:/C:\Users\44984\Documents\Sidz\2010\semester 2\com in Science\Essay\Essay V2.doc|Applied Clinical Trials]], Vol. 19 Issue 6, p82-90.




  • Duthie, S.M, Kimber, I, and Norval, M, 1999, ‘The effects of ultraviolet radiation on the human immune system’, British Journal of Dermatology, 140: pp. 995–1009

  • Linder N, Abudi Y, Abdalla W, Badir M, Amitai Y, Samuels J, Mendelson E and Levy F, 2009, ‘Effect of Season of Inoculation on Immune Response to Rubella Vaccine in Children’, Journal of Tropical Pediatrics Advance Access. doi:10.1093/tropej/fmp104

  • Peña-Cruz, V, McDonough, M.S, Diaz-Griffero, F, Crum, P.C, Carrasco, D.R, Freeman, J.G, 2010, Langerhans Cells Regulate Antigen-Presenting Cell Activity’, [[file:/C:/Users/44984/Documents/Sidz/2010/semester 2/com in Science/Essay/Essay V2.doc|Journal of Investigative Dermatology]],// Vol. 130 Issue 9, pp. 2222-2230